|
DHX8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.604000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.540000E-01 |
| Normal-vs-Stage2 |
6.697200E-01 |
| Normal-vs-Stage3 |
4.224800E-01 |
| Normal-vs-Stage4 |
5.185000E-01 |
| Stage1-vs-Stage2 |
8.707400E-01 |
| Stage1-vs-Stage3 |
6.383800E-01 |
| Stage1-vs-Stage4 |
4.291600E-01 |
| Stage2-vs-Stage3 |
8.456000E-01 |
| Stage2-vs-Stage4 |
4.499000E-01 |
| Stage3-vs-Stage4 |
3.244400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.769040E-01 |
| Normal-vs-AfricanAmerican |
8.577400E-01 |
| Normal-vs-Asian |
8.458200E-01 |
| Caucasian-vs-AfricanAmerican |
4.181800E-01 |
| Caucasian-vs-Asian |
8.628400E-01 |
| AfricanAmerican-vs-Asian |
9.027600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.659200E-01 |
| Normal-vs-Female |
4.580700E-03 |
| Male-vs-Female |
5.997500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.479800E-01 |
| Normal-vs-Extreme_Weight |
6.499600E-01 |
| Normal-vs-Obese |
1.650400E-01 |
| Normal-vs-Extreme_Obese |
9.424400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.836600E-01 |
| Normal_Weight-vs-Obese |
2.305400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.857000E-01 |
| Extreme_Weight-vs-Obese |
1.126440E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.180600E-01 |
| Obese-vs-Extreme_Obese |
4.845200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.816000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.925700E-02 |
| Normal-vs-Age(61-80Yrs) |
9.589000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.283700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.746410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.503800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.570900E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.754100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.693780E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.169800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.092790E-01 |
| Normal-VS-Type2 PRCC |
7.215000E-01 |
| Normal-VS-KIRP CIMP |
1.664820E-01 |
| Normal-VS-Unclassified PRCC |
3.744100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.143610E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.851800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.531620E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.363850E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.456500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.910200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.071200E-01 |
| Normal-vs-N1 |
3.246200E-01 |
| Normal-vs-N2 |
5.618800E-01 |
| N0-vs-N1 |
1.380170E-01 |
| N0-vs-N2 |
3.329000E-01 |
| N1-vs-N2 |
8.592400E-01 |
|
|
